Skip to main content
Journal cover image

Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers.

Publication ,  Journal Article
Wickenheisser, NE; Dillon, M; Broadwater, G; Zacherl, K; Bixel, K; Levine, M; Newton, M; Thel, H; Tucker, K; Gehrig, P; Khetan, VU; Matsuo, K ...
Published in: Gynecol Oncol
December 2023

OBJECTIVE: To compare radical hysterectomy case volume, cancer stage, and biopsy-to-treatment time of invasive cervical cancer diagnosed before and after onset of the COVID-19 pandemic. METHODS: In a multi-institution retrospective cohort study conducted at 6 large, geographically diverse National Cancer Institute-designated cancer centers, patients treated for newly diagnosed invasive cervical cancer were classified into 2 temporal cohorts based on date of first gynecologic oncology encounter: (1) Pre-Pandemic: 3/1/2018-2/28/2020; (2) Pandemic & Recovery: 4/1/2020-12/31/2021. The primary outcome was total monthly radical hysterectomy case volume. Secondary outcomes were stage at diagnosis and diagnosis-to-treatment time. Statistical analyses used chi-squared and two sample t-tests. RESULTS: Between 3/1/2018-12/31/2021, 561 patients were diagnosed with cervical cancer. The Pre-Pandemic and Pandemic & Recovery cohorts had similar age, race, ethnicity, smoking status, and Body Mass Index (BMI). During Pandemic & Recovery, the mean monthly radical hysterectomy case volume decreased from 7[SD 2.8] to 5[SD 2.0] (p = 0.001), the proportion of patients diagnosed with Stage I disease dropped from 278/561 (49.5%) to 155/381 (40.7%), and diagnosis of stage II-IV disease increased from 281/561 (50.1%) to 224/381 (58.8%). Primary surgical management was less frequent (38.3% Pandemic & Recovery versus 46.7% Pre-Pandemic, p = 0.013) and fewer surgically-treated patients received surgery within 6 weeks of diagnosis (27.4% versus 38.9%; p = 0.025). CONCLUSIONS: Lower radical hysterectomy case volume, a shift to higher cervical cancer stage, and delay in surgical therapy were observed across the United States following the COVID-19 outbreak. Decreased surgical volume may result from lower detection of early-stage disease or other factors.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

December 2023

Volume

179

Start / End Page

70 / 78

Location

United States

Related Subject Headings

  • Uterine Cervical Neoplasms
  • United States
  • Retrospective Studies
  • Pandemics
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • National Cancer Institute (U.S.)
  • Hysterectomy
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wickenheisser, N. E., Dillon, M., Broadwater, G., Zacherl, K., Bixel, K., Levine, M., … Havrilesky, L. J. (2023). Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers. Gynecol Oncol, 179, 70–78. https://doi.org/10.1016/j.ygyno.2023.10.010
Wickenheisser, Natalie E., Mairead Dillon, Gloria Broadwater, Kathleen Zacherl, Kristin Bixel, Monica Levine, Meredith Newton, et al. “Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers.Gynecol Oncol 179 (December 2023): 70–78. https://doi.org/10.1016/j.ygyno.2023.10.010.
Wickenheisser, Natalie E., et al. “Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers.Gynecol Oncol, vol. 179, Dec. 2023, pp. 70–78. Pubmed, doi:10.1016/j.ygyno.2023.10.010.
Wickenheisser NE, Dillon M, Broadwater G, Zacherl K, Bixel K, Levine M, Newton M, Thel H, Tucker K, Gehrig P, Khetan VU, Brunette-Masi LL, Matsuo K, Khouri OR, Duhon A, Gowthaman D, Cowan M, Mojdehbakhsh R, Rose S, Olawaiye A, Davidson BA, Moss HA, Havrilesky LJ. Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers. Gynecol Oncol. 2023 Dec;179:70–78.
Journal cover image

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

December 2023

Volume

179

Start / End Page

70 / 78

Location

United States

Related Subject Headings

  • Uterine Cervical Neoplasms
  • United States
  • Retrospective Studies
  • Pandemics
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • National Cancer Institute (U.S.)
  • Hysterectomy
  • Humans
  • Female